ICS still overlooked as first-line asthma therapy: leading GP
Concerns about excessive use of SABAs are reflected in a new global report on managing the condition.
A leading GP has called for wider use of inhaled corticosteroids for both adults and children with asthma to combat the overuse of short-acting beta2 agonists alone.
Dr Kerry Hancock, chair of the RACGP Respiratory Medicine Specific Interest Group, said low-dose inhaled corticosteroids (ICS) were overlooked in asthma management as first-line therapy, despite being recommended in major guidelines.
